Next Article in Journal
Patients with Chronic Obstructive Pulmonary Disease in the Primary Care Setting
Previous Article in Journal
Sprawozdanie z Kongresu European Respiratory Society w Wiedniu, 12–16 września 2009 roku
 
 
Advances in Respiratory Medicine is published by MDPI from Volume 90 Issue 4 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Via Medica.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Acoustic Rhinometry in the Evaluation of Nasal Lysine Aspirin Challenge

by
Maciej Kupczyk
1,
Izabela Kupryś-Lipińska
1,
Małgorzata Bocheńska-Marciniak
2 and
Piotr Kuna
1,*
1
Department of Internal Diseases, Asthma, and Allergies, Medical University of Łódź, 90-153 Łódź, Poland
2
Department of Pneumonology and Allergies, Medical University of Łódź, 90-153 Łódź, Poland
*
Author to whom correspondence should be addressed.
Adv. Respir. Med. 2010, 78(2), 103-111; https://doi.org/10.5603/ARM.27735
Submission received: 7 November 2009 / Revised: 19 March 2010 / Accepted: 19 March 2010 / Published: 19 March 2010

Abstract

Background: Nasal lysine aspirin (Lys-ASA) challenge is an alternative to oral and bronchial challenges in the diagnosis of hypersensitivity to acetylsalicylic acid (ASA) and other non-steroid anti-inflammatory drugs (NSAIDs). The aim of the study was to evaluate the sensitivity and specificity of acoustic rhinometry as an objective method of evaluation of nasal Lys-ASA challenge. Material and methods: We enrolled 20 patients with ASA-induced asthma confirmed by oral challenge (ASA-S group), 5 patients with allergic rhinitis without hypersensitivity to NSAIDs, and 5 healthy individuals (ASA-NS group). All the subjects underwent challenge with placebo (0.9% NaCl) or 14.4 mg of Lys-ASA applied in a spray into both nostrils (total dose: 16 mg of ASA). Measurements of nasal volume bilaterally were performed with an acoustic rhinometer before and 1, 2, 4, and 24 hours after the challenge. For further calculations we used the sum of both nasal volumes at 2 to 5 cm from the nostrils. Results: The mean total nasal volume in the AIA group before and 1, 2, 4, and 24 hours after the challenge was 7.75, 6.21, 7.11, 7.12, and 7.24 cm3 following placebo, respectively, and 7.24, 5.77, 6.31, 6.27, and 6.98 cm3 following Lys-ASA, respectively (p = 0.048 and p = 0.02 at 2 and 4 hours, Lys-ASA vs. placebo, Wilcoxon test). With the cutoff value of nasal volume reduction of 10%, the test sensitivity was 70%, the specificity was 60%, the positive predictive value was 77.78%, and the negative predictive value was 50% at 1 hour after the challenge. Conclusions: Acoustic rhinometry with the measurement of nasal volume at 2 to 5 cm from the nostrils proved insufficiently sensitive or specific to be used as the sole method for evaluation of nasal Lys-ASA challenge.
Keywords: aspirin; acoustic rhinometry; nasal challenge aspirin; acoustic rhinometry; nasal challenge

Share and Cite

MDPI and ACS Style

Kupczyk, M.; Kupryś-Lipińska, I.; Bocheńska-Marciniak, M.; Kuna, P. Acoustic Rhinometry in the Evaluation of Nasal Lysine Aspirin Challenge. Adv. Respir. Med. 2010, 78, 103-111. https://doi.org/10.5603/ARM.27735

AMA Style

Kupczyk M, Kupryś-Lipińska I, Bocheńska-Marciniak M, Kuna P. Acoustic Rhinometry in the Evaluation of Nasal Lysine Aspirin Challenge. Advances in Respiratory Medicine. 2010; 78(2):103-111. https://doi.org/10.5603/ARM.27735

Chicago/Turabian Style

Kupczyk, Maciej, Izabela Kupryś-Lipińska, Małgorzata Bocheńska-Marciniak, and Piotr Kuna. 2010. "Acoustic Rhinometry in the Evaluation of Nasal Lysine Aspirin Challenge" Advances in Respiratory Medicine 78, no. 2: 103-111. https://doi.org/10.5603/ARM.27735

Article Metrics

Back to TopTop